#273: Improving Adverse Drug Reaction Information in Product Labels
Chair
Senior Research Advisor, Global Statistical Sciences, Eli Lilly and Company
Brenda Crowe is a Senior Research Advisor at Eli Lilly and Company (Lilly) where she leads a Safety Analytics team. She obtained a PhD in Statistics from the University of Toronto in 1997 and has 20 years of pharmaceutical industry experience.
Speakers PR
Head, Epidemiology Analytics, Janssen Pharmaceuticals, Inc.
Patrick Ryan, PhD is Senior Director of Epidemiology and the Head of Epidemiology Analytics at Janssen Research and Development. He is currently a collaborator in Observational Health Data Sciences and Informatics (OHDSI, htttp://ohdsi.org). He served as a principal investigator of...
Read More →
Principal, Navitas Inc.
He has been a business consultant for more than 14 years. Since joining WCI, he has helped global pharmaceutical clients to optimize their processes in regards of content management, different compliance related issues, risk management and Pharmacovigilance.
Director, Office of Drug Evaluation I, OND, CDER, FDA
Ellis F. Unger is the Director, Office of Drug Evaluation-I, Office of New Drugs, Center for Drug Evaluation and Research, FDA. His Office oversees the regulation of drugs for cardiovascular, renal, neurological, and psychiatric disorders. Dr. Unger is a board-certified internist...
Read More →
Tuesday June 28, 2016 4:00pm - 5:15pm EDT
109AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 15: Statistics,
Session
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Labeling, Topics Related to Europe-EMEA
- Interest Area Clinical Safety & Pharmacovigilance, Regulatory Affairs
- format json
- Interest Area Clinical Safety & Pharmacovigilance,Regulatory Affairs
- Featured Topics Labeling,Topics Related to Europe/EMEA
- Credit Type ACPE, CME, IACET, RN
- Tags Session